腋窝淋巴结细针穿刺活检可用于乳腺癌分期
该研究回顾了354例腋窝淋巴结超声引导下细针穿刺活检(FNAB)样本,并与腋窝清扫或术中前哨淋巴结活检(SLNB)的组织学结果对照。在仅计阳性和阴性FNAB样本(n=330,93.2%)时,诊断敏感度为89.4%、特异度为99.2%。作者认为FNAB在相当比例患者中可作为SLNB的合适替代,但FNAB阴性者仍应行标准SLNB。
要点
- FNAB阳性与阴性样本合计330例时,敏感度89.4%、特异度99.2%。
- 143例FNAB阴性样本中22例(15.4%)经SLNB或ALND证实为阳性。
- FNAB阴性尤其影像异常淋巴结者,仍应行标准SLNB。
核心结论
- 腋窝淋巴结FNAB在相当比例患者中可作为检测乳腺来源淋巴结转移的合适替代方法。
- 但FNAB阴性者仍应行标准SLNB,尤其是影像学表现异常的淋巴结。
研究设计与样本
- 回顾性检索并复核超声引导下腋窝淋巴结FNAB样本及同侧乳腺组织样本。
- 对照组合计腋窝清扫组织学结果或术中SLNB结果。
- 共纳入354例与组织学结果配对的腋窝淋巴结FNAB样本。
主要发现
- 187例(52.8%)为乳腺来源转移癌阳性。
- 143例(40.4%)为转移阴性。
- 12例(3.4%)见不典型细胞,6例(1.7%)可疑转移,6例(1.7%)因缺乏淋巴组织和恶性细胞而无法诊断。
- 143例FNAB阴性样本中,22例(15.4%)经术中SLNB或ALND为阳性。
- 仅计阳性和阴性FNAB样本(n=330,93.2%)时,总体诊断敏感度为89.4%、特异度为99.2%。
关键数值与推荐
- FNAB阳性187例(52.8%)、阴性143例(40.4%)、不典型12例(3.4%)、可疑转移6例(1.7%)、无法诊断6例(1.7%)。
- 阳性和阴性FNAB合计330例(93.2%),敏感度89.4%、特异度99.2%。
- FNAB阴性样本中15.4%(22/143)经SLNB或ALND证实阳性。
临床怎么用
- 腋窝淋巴结FNAB可用于新诊断乳腺癌患者的腋窝分期评估,阳性结果有助于避免不必要的SLNB。
- FNAB阴性不能排除转移,应行标准SLNB,影像学异常淋巴结尤需注意。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pathologic evaluation of sentinel lymph node biopsy (SLNB) samples is crucial for axillary staging in patients newly diagnosed with breast cancer. Patients with pathologic evidence of nodal metastasis scheduled for upfront surgery typically also undergo axillary lymph node dissection (ALND). Although SLNB is the gold standard method for detecting nodal metastasis, axillary lymph node fine-needle aspiration biopsy (FNAB) utility has not been thoroughly explored. METHODS: Ultrasound-guided axillary lymph node FNAB samples along with concurrent ipsilateral breast tissue samples were searched and reviewed. The control group included histologic findings of axillary dissection or intraoperative SLNB results. RESULTS: A total of 354 axillary lymph node FNAB samples with matched histology were included. Of these, 187 (52.8%) were positive for metastatic carcinoma of breast origin; 143 (40.4%) were negative for metastasis; 12 (3.4%) showed atypical cells; six (1.7%) were suspicious for metastasis; and six (1.7%) were nondiagnostic because of a lack of lymphoid tissue and malignant cells. Of the 143 negative FNAB samples, 22 (15.4%) were positive on either intraoperative SLNB or ALND. When only the positive and negative FNAB samples were accounted for (n = 330; 93.2%), overall diagnostic sensitivity and specificity were 89.4% and 99.2%, respectively. CONCLUSIONS: Although axillary SLNB is the standard procedure for detecting nodal metastasis of breast origin, axillary lymph node FNAB appears to be a suitable alternative in a significant proportion of patients. A standard SLNB should be performed in cases of negative axillary lymph node FNAB findings, particularly nodes with abnormal imaging findings.
引用
- Sallout L, Tashkandi M, Moqnas A, et al. Fine-needle aspiration biopsy of axillary lymph nodes: A reliable diagnostic tool for breast cancer staging. Cancer Cytopathol. 2023. PMID: 37843531. doi:10.1002/cncy.22770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。